ALPINE IMMUNE SCIENCES INC (ALPN)
US02083G1004 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -36.83M | -32.18M | -57.76M | -50.33M | -27.94M | |||
| Depreciation Amortization | 583.00K | 576.00K | 600.00K | 620.00K | 580.00K | |||
| Income Taxes - Deferred | N/A | 155.00K | 50.00K | -210.00K | 0.00 | |||
| Change In Working Capital | -47.44M | -50.16M | 4.15M | 27.26M | 52.94M | |||
| Interest Paid | N/A | 66.00K | 320.00K | 550.00K | 490.00K | |||
| Taxes Paid | N/A | 1.53M | N/A | N/A | N/A | |||
| Other non cash items | 2.98M | 2.60M | 9.22M | 7.42M | 4.51M | |||
| OPERATING CASH FLOW | -80.55M | -79.01M | -43.75M | -15.25M | 30.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -416.00K | -487.00K | -410.00K | -120.00K | -800.00K | |||
| Other Investing Activity | -86.06M | -55.07M | -112.94M | -52.36M | -72.02M | |||
| INVESTING CASH FLOW | -86.47M | -55.56M | -113.35M | -52.48M | -72.82M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.23M | -3.42M | -4.80M | -2.40M | 5.00M | |||
| Stock Issued/Repurchased | 187.80M | 168.55M | 107.49M | 103.16M | 56.38M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 185.56M | 165.12M | 102.69M | 100.76M | 61.38M | |||
| Exchange Rate Effect | 24.00K | 8.00K | -120.00K | -90.00K | 60.00K | |||
| CHANGE IN CASH | 18.56M | 30.56M | -54.53M | 32.94M | 18.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -80.55M | -79.01M | -43.75M | -15.25M | 30.08M | |||
| Capital Expenditure | -416.00K | -487.00K | -410.00K | -120.00K | -800.00K | |||
| FREE CASH FLOW | -80.97M | -79.50M | -44.16M | -15.37M | 29.28M | |||
All data in USD